Myeloma Investment Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
27
- Portfolio
-
16
- Exits
-
6
Myeloma Investment Fund General Information
Company Description
Founded in 2019, Myeloma Investment Fund is a not-for-profit venture capital firm of Multiple Myeloma Research Foundation based in Norwalk, Connecticut. The firm seeks to invest in healthcare sector.
Business Details
Website
www.myelomainvestmentfund.orgYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 383 Main Avenue
- 7th floor
- Norwalk, CT 06851
- United States
Myeloma Investment Fund Investments (27)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Coding Bio | 13-Feb-2026 | Seed Round | Drug Discovery | Generating Revenue | ||
| Indapta Therapeutics | 10-Oct-2025 | Drug Discovery | Generating Revenue | |||
| Stylus Medicine | 13-May-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Reverb Therapeutics | 19-Feb-2025 | Other Healthcare Services | Pre-Clinical Trials | |||
| Luminary Therapeutics | 27-Jan-2025 | Drug Discovery | Generating Revenue | |||
| Umoja Biopharma | 19-Jan-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| TRIO Pharmaceuticals | 07-Nov-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Envisagenics | 18-Jul-2024 | Discovery Tools (Healthcare) | Pre-Clinical Trials | |||
| Dynamic Cell Therapies | 11-Jul-2024 | Seed Round | Drug Discovery | Out of Business | ||
| Nammi Therapeutics | 01-Jul-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Myeloma Investment Fund Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Dynamic Cell Therapies | 28-Apr-2026 | Out of Business | |
| Cullinan Mica | 12-Apr-2024 | ||
| Tidal Therapeutics | 09-Apr-2021 | ||
| NexImmune | 12-Feb-2021 | ||
| Cullinan Therapeutics | 08-Jan-2021 | IPO | |
| Luminary Therapeutics | Secondary Transaction - Private |
Myeloma Investment Fund Investments by Industry, Year, and Region
Myeloma Investment Fund Co-Investors (67)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Leaps by Bayer | 2 |
|
|
||
| Northpond Ventures |
|
|
|||
| RA Capital Management |
|
|
|||
| Johnson & Johnson JJDC |
|
|
|||
| Leerink Partners |
|
|
Myeloma Investment Fund FAQs
-
What is Myeloma Investment Fund?
Founded in 2019, Myeloma Investment Fund is a not-for-profit venture capital firm of Multiple Myeloma Research Foundation based in Norwalk, Connecticut.
-
When was Myeloma Investment Fund founded?
Myeloma Investment Fund was founded in 2019.
-
Where is Myeloma Investment Fund headquartered?
Myeloma Investment Fund is headquartered in Norwalk, CT.
-
What is Myeloma Investment Fund's total asset value?
Myeloma Investment Fund has around in total assets under management.
-
How many investments has Myeloma Investment Fund made?
Myeloma Investment Fund has made 27 investments.
-
What has Myeloma Investment Fund invested in?
Myeloma Investment Fund has made numerous investments in companies like Coding Bio, Indapta Therapeutics, and Stylus Medicine within the Drug Discovery industry.
-
What has Myeloma Investment Fund invested in recently?
Myeloma Investment Fund's latest investment was on 13-Feb-2026 in Coding Bio, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process